R&D
Agentic AI and the human element: Building trustworthy autom...
The future of clinical trials isn’t about replacing people. It’s about empowering them with smarter tools.
News
Boehringer bets up to $500m on Sitryx immunology programme
Boehringer Ingelheim's partnership with Sitryx is focused on a family of small-molecule drugs for autoimmune and inflammatory diseases.
News
Lilly says orforglipron tops Wegovy pill in diabetes trial
Lilly's head-to-head trial of oral GLP-1 orforglipron and Novo Nordisk's oral Wegovy in type 2 diabetes raises as many questions as it answers.
News
Asahi Kasei buys antiviral firm Aicuris for €780m
Asahi Kasei has agreed to buy Germany's Aicuris for around $920m, adding an antiviral drug it hopes will help drive its 2030 pharma sales to $1.9bn.
News
Changes at the top of Sarepta, Alkermes, as CEOs depart
Two long-serving pharma CEOs have announced their departures, as Sarepta's Doug Ingram and Alkermes' Richard Pops announce their retirement.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
